Autologous stem cell transplantation in a patient with scleromyxedema

por Nathan, Sunita, Ustun, Celalettin
Publicado 2022

UCB HCT in FLT3+ AML

por Ustun, Celalettin, Ruggeri, Annalisa, Weisdorf, Daniel J.
Publicado 2017

Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia

por DeRemer, David L, Katsanevas, Katerina, Ustun, Celalettin
Publicado 2011

Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach

por Courville, Elizabeth L., Griffith, Megan, Ustun, Celalettin, Yohe, Sophia, Warlick, Erica
Publicado 2017

Presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis

por Tran, Tu M., Najafi, Mehdi, Ambros, Tadeu, Pulido, Jose S., Ustun, Celalettin, Koozekanani, Dara
Publicado 2020

Scedosporium infection disseminated “from toe to head” in allogeneic stem cell transplant recipient: a case report

por Marinovic, Debra A., Bhaimia, Eric, Forrest, Graeme N., LaRue, Rebecca, Nathan, Sunita, Ustun, Celalettin, Ward, Anna
Publicado 2023

Human herpesvirus 6 is associated with status epilepticus and hyponatremia after umbilical cord blood transplantation

por de Souza Franceschi, Fernanda Leite, Green, Jaime, Cayci, Zuzan, Mariash, Evan, Ezzeddine, Mustapha, Bachanova, Veronika, Ustun, Celalettin
Publicado 2014

Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis

por Cavazos, Karla, Eswaran, Sheila, Maidlow, Cathleen, Keklik Karadag, Fatma, Idilman, Ramazan, Idilman, Ilkay, Miller, Ira, Shammo, Jamile, Reau, Nancy, Ustun, Celalettin
Publicado 2022

COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter

por Varma, Ankur, Kosuri, Satyajit, Ustun, Celalettin, Ibrahim, Uroosa, Moreira, Jonathan, Bishop, Michael R., Nathan, Sunita, Mehta, Jayesh, Moncayo, Daniel, Heng, Joseph, Osman, Keren, Adekola, Kehinde U. A.
Publicado 2020

Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental Study

por Özen, Mehmet, Üstün, Celalettin, Öztürk, Bengi, Topçuoğlu, Pervin, Arat, Mutlu, Gündüz, Mehmet, Atilla, Erden, Bolat, Gülşen, Arslan, Önder, Demirer, Taner, Akan, Hamdi, İlhan, Osman, Beksaç, Meral, Gürman, Günhan, Özcan, Muhit
Publicado 2017

Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts

por Valent, Peter, Akin, Cem, Arock, Michel, Gleixner, Karoline V., Greinix, Hildegard, Hermine, Olivier, Horny, Hans-Peter, Ivanov, Daniel, Orfao, Alberto, Rabitsch, Werner, Reiter, Andreas, Schulenburg, Axel, Sotlar, Karl, Sperr, Wolfgang R., Ustun, Celalettin
Publicado 2023

OUTCOMES OF UCB TRANSPLANTATION ARE COMPARABLE IN FLT3+ AML: RESULTS OF CIBMTR, EUROCORD AND EBMT COLLABORATIVE ANALYSIS

por Ustun, Celalettin, Giannotti, Federica, Zhang, Mei-Jie, Wang, Hai-Lin, Brunstein, Claudio, Labopin, Myriam, Rocha, Vanderson, de Lima, Marcos, Baron, Frédéric, Sandmaier, Brenda M., Eapen, Mary, Gluckman, Eliane, Nagler, Arnon, Weisdorf, Daniel J., Ruggeri, Annalisa
Publicado 2017

Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies

por Behrens, Elizabeth, Timmermann, Anne, Yerkan, Alexander, Katz, Deborah A., Paner, Agne, Larson, Melissa C., Kim, Seo-Hyun, Jain, Shivi, Gezer, Sefer, Venugopal, Parameswaran, Dehghan-Paz, Irene, Rhee, Yoona, Ustun, Celalettin, Varma, Ankur, Shammo, Jamile M.
Publicado 2020

Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis

por Buckley, Sarah A., Wood, Brent L., Othus, Megan, Hourigan, Christopher S., Ustun, Celalettin, Linden, Michael A., DeFor, Todd E., Malagola, Michele, Anthias, Chloe, Valkova, Veronika, Kanakry, Christopher G., Gruhn, Bernd, Buccisano, Francesco, Devine, Beth, Walter, Roland B.
Publicado 2017

Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics

por Keklik, Fatma, Alrawi, Ezzideen Barjes, Cao, Qing, Bejanyan, Nelli, Rashidi, Armin, Lazaryan, Aleksandr, Arndt, Patrick, Dincer, Erhan H., Bachanova, Veronika, Warlick, Erica D., MacMillan, Margaret L., Arora, Mukta, Miller, Jeffrey, Brunstein, Claudio G, Weisdorf, Daniel J., Ustun, Celalettin
Publicado 2018

Age is no Barrier for Adults undergoing HCT for AML in CR1: Contemporary CIBMTR Analysis

por Maakaron, Joseph E., Zhang, Mei-Jie, Chen, Karen, Abhyankar, Sunil, Bhatt, Vijaya Raj, Chhabra, Saurabh, Jurdi, Najla El, Farag, Sherif S., He, Fiona, Juckett, Mark, de Lima, Marcos, Majhail, Navneet, van der Poel, Marjolein, Saad, Ayman, Savani, Bipin, Ustun, Celalettin, Waller, Edmund K., Litzow, Mark, Kebriaei, Partow, Hourigan, Christopher S., Saber, Wael, Weisdorf, Daniel
Publicado 2022

Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts

por Valent, Peter, Akin, Cem, Hartmann, Karin, Nilsson, Gunnar, Reiter, Andreas, Hermine, Olivier, Sotlar, Karl, Sperr, Wolfgang R., Escribano, Luis, George, Tracy I., Kluin-Nelemans, Hanneke C., Ustun, Celalettin, Triggiani, Massimo, Brockow, Knut, Gotlib, Jason, Orfao, Alberto, Kovanen, Petri T., Hadzijusufovic, Emir, Sadovnik, Irina, Horny, Hans-Peter, Arock, Michel, Schwartz, Lawrence B., Austen, K. Frank, Metcalfe, Dean D., Galli, Stephen J.
Publicado 2020

Selective Inhibition of FLT3 by Gilteritinib in Relapsed/Refractory Acute Myeloid Leukemia: a Multicenter, First-in-human, Open-label, Phase 1/2 Study

por Perl, Alexander E., Altman, Jessica K., Cortes, Jorge, Smith, Catherine, Litzow, Mark, Baer, Maria R., Claxton, David, Erba, Harry P., Gill, Stan, Goldberg, Stuart, Jurcic, Joseph G., Larson, Richard A., Liu, Chaofeng, Ritchie, Ellen, Schiller, Gary, Spira, Alexander I., Strickland, Stephen A., Tibes, Raoul, Ustun, Celalettin, Wang, Eunice S., Stuart, Robert, Röllig, Christoph, Neubauer, Andreas, Martinelli, Giovanni, Bahceci, Erkut, Levis, Mark
Publicado 2017

Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR(®) study

por Maziarz, Richard T., Brazauskas, Ruta, Chen, Min, McLeod, Aleksandra A., Martino, Rodrigo, Wingard, John R., Aljurf, Mahmoud, Battiwalla, Minoo, Dvorak, Christopher C., George, Biju, Guinan, Eva C., Hale, Gregory A., Lazarus, Hillard M., Lee, Jong-Wook, Liesveld, Jane L., Ramanathan, Muthalagu, Reddy, Vijay, Savani, Bipin N., Smith, Franklin O., Strasfeld, Lynne, Taplitz, Randy A., Ustun, Celalettin, Boeckh, Michael J., Gea-Banacloche, Juan, Lindemans, Caroline A., Auletta, Jeffery J., Riches, Marcie L.
Publicado 2016

Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia

por Desai, Pinkal M., Brown, Janice, Gill, Saar, Solh, Melham M., Akard, Luke P., Hsu, Jack W., Ustun, Celalettin, Andreadis, Charalambos, Frankfurt, Olga, Foran, James M., Lister, John, Schiller, Gary J., Wieduwilt, Matthew J., Pagel, John M., Stiff, Patrick J., Liu, Delong, Khan, Irum, Stock, Wendy, Kambhampati, Suman, Tallman, Martin S., Morris, Lawrence, Edwards, John, Pusic, Iskra, Kantarjian, Hagop M., Mamelok, Richard, Wong, Alicia, Van Syoc, Rodney, Kellerman, Lois, Panuganti, Swapna, Mandalam, Ramkumar, Abboud, Camille N., Ravandi, Farhad
Publicado 2021